PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 6 days 22 hours 11 minutes
Going Below the Surface in Advanced Basal Cell Carcinoma: Analysing the Latest Evidence
Going Below the Surface in Advanced Basal Cell Carcinoma: Analysing the Latest Evidence
Personalizing Care for Patients With Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma: A Case-Based Approach
Personalizing Care for Patients With Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma: A Case-Based Approach
Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy
Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy
A Heart to Heart in Cardio-Oncology: Optimizing Cardiovascular Health With BTK Inhibitors for CLL
A Heart to Heart in Cardio-Oncology: Optimizing Cardiovascular Health With BTK Inhibitors for CLL
Current and Emerging Radiopharmaceuticals for Prostate Cancer: Is There a Role for Both?
Current and Emerging Radiopharmaceuticals for Prostate Cancer: Is There a Role for Both?
Quality of Life in Patients With Advanced Renal Cell Carcinoma: Are We Measuring What Matters?
Quality of Life in Patients With Advanced Renal Cell Carcinoma: Are We Measuring What Matters?
Elevating Care in Multiple Myeloma: Translating the Latest Evidence to Clinical Practice in Canada
Elevating Care in Multiple Myeloma: Translating the Latest Evidence to Clinical Practice in Canada
Optimizing Care in GEP-NET: Are All Somatostatin Analogues Created Equal?
Optimizing Care in GEP-NET: Are All Somatostatin Analogues Created Equal?
Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?
Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?
PARPs in Practice in mCRPC: A Look at the Latest Data
PARPs in Practice in mCRPC: A Look at the Latest Data